Call for paper 〔OPEN〕

My submissions

Registration 〔OPEN〕

My tickets


It is with great pleasure to announce and to invite you to join us at The 2nd Asia Pacific Symposium on Diabetes, Hypertension, Metabolic Syndrome and Pregnancy - DIPAP Greater China to take place this coming October 26-28, 2017 in Shanghai, China.

The Symposium is held in order to highlight and document scientifically and practically on how to prevent, diagnose and manage HIP to optimize care and outcomes in what is seen as a large knowledge gap within the field. 

Call for paper

Important date

Abstract submission deadline

Submission Topics

  • The Non Communicable Disease & Pregnancy global epidemic - It’s all about the mother and the offspring

  • The Non Communicable Disease & Pregnancy – The FIGO Global vision

  • The IDF Global Vision: Diabetes in Pregnancy

  • Maternal Health – The Impact of Diabetes, Obesity, Hypertension in Pregnancy

  • The Mother with Pregnancy Induced Complications – How do we Improve Outcome?

  • The Fetus - Is There an Optimal Birth Weight?

  • The Fetus - Prevention of Preterm Birth: Towards Healthy Mothers and Healthy Babies

  • Renovating Maternal Fetal Medicine

  • Maternal Fetal Medicine - The Great Obstetrical Syndromes; from basics to molecular biology

  • Fetal Medicine - Innovations in prediction and prevention

  • New technologies in diabetic pregnancy

  • Placental insufficiency: preeclampsia and fetal growth

  • The pathogenesis of preeclampsia: Clues to prevention and treatment

  • Preeclampsia: identification of pre-clinical disease and management issues

  • Early prediction and prevention of IUGR

  • IUGR and SGA: Doppler management and prediction of outcomeObesity or Metabolic Syndrome in Pregnancy, which is more hazardous to the mother and offspring?

  • Perinatal programming of obesity

  • Pre-pregnancy management of the obese patient

  • Health system and societal barriers in improving diabetes related maternal health

  • Towards a Consensus; The FIGO-GDM Initiative Project

  • The Asia Pacific Experience: Learning from the SAIDIP & Greater China experience

  • Tribulations and triumphs in implementing a national strategy for GDM screening diagnosis and care in India

  • Analysis of the cost-effectiveness of carrying out GDM screening in India

  • Gestational diabetes mellitus in China: Difficulties and coping strategies

  • Analysis of the cost-effectiveness of carrying out GDM screening in China

  • State of the art on insulin analogues and pregnancy

  • Differences between early and late onset placental disease - implications for screening

  • Aspects of preeclampsia risk calculation: Populations and individuals

  • First-trimester maternal risk assessment - A health economic perspective

  • Critical evaluation of potential treatments: The case for/against aspirin

  • Towards a solution - The ASPRE Study

  • Nutritional factors and supplementation on maternal and infant outcome

  • Diet and pregnancy outcomes- examples based on the role of micronutrients and macronurients in the development of gestational diabetes

  • Nutritional supplementation and the prevention of fetal congenital abnormalitie

  • Differences in growth trajectories between infants of women with type-1 and type-2 diabetes?

Submit Comment
Verify Code Change Another
All Comments
Important Date
  • Conference Date

    Oct 27



    Oct 28


  • Sep 26 2017

    Abstract Submission Deadline

Contact Information